Metabolic syndrome may increase prostate cancer risk

07/5/2013 | Renal and Urology News

Men with three or more metabolic syndrome components were 38% more likely than those with no risk factors to be diagnosed with prostate cancer and had a 52% higher risk of clinically significant prostate cancer and a 43% higher risk of high-grade prostate cancer, a Canadian study showed. The findings were presented at the Canadian Urological Association's 2013 meeting.

View Full Article in:

Renal and Urology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD